Overhage JM - Search Results

1

Authors' reply to Hennessy and Leonard's comment on "Desideratum for evidence-based epidemiology".

Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Overhage JM, et al. Drug Saf. 2015 Jan;38(1):105-7. doi: 10.1007/s40264-014-0254-8. Drug Saf. 2015. PMID: 25511912 No abstract available.

2

Desideratum for evidence based epidemiology.

Overhage JM, Ryan PB, Schuemie MJ, Stang PE. Overhage JM, et al. Drug Saf. 2013 Oct;36 Suppl 1:S5-14. doi: 10.1007/s40264-013-0102-2. Drug Saf. 2013. PMID: 24166219 Review.

3

Variation in choice of study design: findings from the Epidemiology Design Decision Inventory and Evaluation (EDDIE) survey.

Stang PE, Ryan PB, Overhage JM, Schuemie MJ, Hartzema AG, Welebob E. Stang PE, et al. Among authors: overhage jm. Drug Saf. 2013 Oct;36 Suppl 1:S15-25. doi: 10.1007/s40264-013-0103-1. Drug Saf. 2013. PMID: 24166220

4

Managing data quality for a drug safety surveillance system.

Hartzema AG, Reich CG, Ryan PB, Stang PE, Madigan D, Welebob E, Overhage JM. Hartzema AG, et al. Among authors: overhage jm. Drug Saf. 2013 Oct;36 Suppl 1:S49-58. doi: 10.1007/s40264-013-0098-7. Drug Saf. 2013. PMID: 24166223

5

A comparison of the empirical performance of methods for a risk identification system.

Ryan PB, Stang PE, Overhage JM, Suchard MA, Hartzema AG, DuMouchel W, Reich CG, Schuemie MJ, Madigan D. Ryan PB, et al. Among authors: overhage jm. Drug Saf. 2013 Oct;36 Suppl 1:S143-58. doi: 10.1007/s40264-013-0108-9. Drug Saf. 2013. PMID: 24166231

6

Bridging islands of information to establish an integrated knowledge base of drugs and health outcomes of interest.

Boyce RD, Ryan PB, Norén GN, Schuemie MJ, Reich C, Duke J, Tatonetti NP, Trifirò G, Harpaz R, Overhage JM, Hartzema AG, Khayter M, Voss EA, Lambert CG, Huser V, Dumontier M. Boyce RD, et al. Among authors: overhage jm. Drug Saf. 2014 Aug;37(8):557-67. doi: 10.1007/s40264-014-0189-0. Drug Saf. 2014. PMID: 24985530 Free PMC article.

7

Empirical assessment of methods for risk identification in healthcare data: results from the experiments of the Observational Medical Outcomes Partnership.

Ryan PB, Madigan D, Stang PE, Overhage JM, Racoosin JA, Hartzema AG. Ryan PB, et al. Among authors: overhage jm. Stat Med. 2012 Dec 30;31(30):4401-15. doi: 10.1002/sim.5620. Epub 2012 Sep 27. Stat Med. 2012. PMID: 23015364

8

Evaluating the impact of database heterogeneity on observational study results.

Madigan D, Ryan PB, Schuemie M, Stang PE, Overhage JM, Hartzema AG, Suchard MA, DuMouchel W, Berlin JA. Madigan D, et al. Among authors: overhage jm. Am J Epidemiol. 2013 Aug 15;178(4):645-51. doi: 10.1093/aje/kwt010. Epub 2013 May 5. Am J Epidemiol. 2013. PMID: 23648805 Free PMC article.

9

The Impact of Censoring Drug Switching in Medication Adherence Measures of Chronic Single Ingredient Oral Drugs.

Zhu VJ, Overhage JM, Ma Q, Ryan PB. Zhu VJ, et al. Among authors: overhage jm. Stud Health Technol Inform. 2017;245:1200-1204. Stud Health Technol Inform. 2017. PMID: 29295293

10

Validation of a common data model for active safety surveillance research.

Overhage JM, Ryan PB, Reich CG, Hartzema AG, Stang PE. Overhage JM, et al. J Am Med Inform Assoc. 2012 Jan-Feb;19(1):54-60. doi: 10.1136/amiajnl-2011-000376. Epub 2011 Oct 28. J Am Med Inform Assoc. 2012. PMID: 22037893 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

185 results

Search Page